Literature DB >> 2702045

Treatment of polymyositis and dermatomyositis.

M Dalakas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2702045     DOI： 10.1097/00002281-198901040-00005

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN： 1040-8711            Impact factor:   5.006


× No keyword cloud information.
  5 in total

Review 1.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

2.  Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies: effects on clinicopathological features and immunoregulatory genes.

Authors:  Marinos C Dalakas
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

3.  Idiopathic inflammatory myopathy: treatment options.

Authors:  Stephen J DiMartino
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

Review 4.  Idiopathic inflammatory myopathies: a treatment update.

Authors:  Chester V Oddis
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

5.  Polymyositis associated with chronic myelogenous leukemia.

Authors:  L C Pagliaro; P Mancias
Journal:  Ann Hematol       Date:  1994-04       Impact factor: 3.673
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.